market cap $92m, $60-$64m revenue forecast with growth trend regardless of IMOD, good margin business, $12m cash, no debt, investing in growth with new GM for example, a new product that we can be confident will bring new strong high margin revenue, vaccines rolling out
more bumps for sure in the short term but if you can pull out a year there is only one bump you will see. I am biased but i will also keep topping up. I am personally torn as to whether i want to see the share continue to decline or rise
AVA chart, page-430
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
